Innovative Discoveries Series

Engineering Better Healthcare: From Stopwatches to Systems Optimization

Rooted in manufacturing and mechanical engineering, industrial (and systems) engineering was developed during the Industrial Revolution. The discipline that was originally intended to streamline workflow and improve industrial productions has grown significantly since then. Industrial Engineering methods have also been applied to various industries such as aerospace, finance, logistics, and most recently, healthcare.

Since Industrial Engineer has not been a traditional role in healthcare, this talk will provide examples of some applications of industrial engineering techniques in healthcare including here at Christiana, as well as explore future healthcare applications including hospital operations, medical treatments, health policy and population health.

Presented By:

Tze Chaim, PhD

Director, Health Systems Optimization, Value Institute, Christiana Care Health System

Free!  Lunch will be served!

This activity has been approved for AMA PRA Category 1 Credit.

REGISTER ONLINE TODAY!

Friday, July 26, 2019
Noon to 1 p.m.
In-person: Christiana Hospital,Room 1100
Online: Watch live at https://bluejeans.com/361095905
Or join meeting ID 361095905 on the BlueJeans app on your smartphone or tablet

This activity has been approved for AMA PRA Category 1 Credit.

Upcoming Lectures:

August 9: Transition from Hospital to Home Health Care

Statement on Vaccines

Vaccines Continue to be Tested and Proven Safe

American Academy of Pediatrics. (2017). American Academy of Pediatrics Emphasizes Safety and Importance of Vaccines. Retrieved from https://www.aap.org/en-us/about-the-aap/aap-press-room/Pages/American-Academy-of-Pediatrics-Emphasizes-Safety-and-Importance-of-Vaccines.aspx

Centers for Disease Control and Prevention. (2016). Infant Immunizations FAQs. Retrieved from https://www.cdc.gov/vaccines/parents/parent-questions.html

Institute of Medicine. (2004). Immunization Safety Review: Vaccines and Autism. Retrieved from https://www.nap.edu/catalog/10997/immunization-safety-review-vaccines-and-autism

U.S. Food and Drug Administration. (2015).  Thimerosal in Vaccines: Questions and Answers. Retrieved from http://www.fda.gov/BiologicsBloodVaccines/Vaccines/QuestionsaboutVaccines/UCM070430#q5

In light of recent claims by politicians or appointees that vaccines are linked to autism, or are unsafe when administered according to the recommended schedule, or contain dangerous products like Thimerosal, the public health community and the Delaware Academy of Medicine/Delaware Public Health Association continue to come down on the side of science.

The Food and Drug Administration (FDA) Center for Biologics Evaluation and Research is responsible for regulating vaccines in the United States.  Before a vaccine can be licensed for public use, it must be tested for safety in the laboratory, in animals, and in human clinical trials.  Human clinical trials include looking for common adverse events in a few participants (phase 1), several hundred volunteers looking for local reactions and general side effects like fever (phase 2), and establishing the effectiveness of the vaccine and determining less common side effects with thousands of participants (phase 3).  If a vaccine is to be given at the same time as another vaccine, the two vaccines are tested together (FDA, 2015).  If a dangerous effect is found, that vaccine is not licensed for public use.

Vaccines are continuously monitored following licensure by the Vaccine Adverse Event Reporting System (VAERS), which is run by both the FDA and the Centers for Disease Control (CDC).  The VAERS is a national system that collects all reports of adverse events following vaccination.  Phase 4 clinical studies are also conducted to further evaluate the new vaccine, and population based studies are conducted through the use of databases like the Vaccine Safety Datalink (VSD) for the lifetime of the use of the vaccine (FDA, 2015).

The Institute of Medicine (IOM) Immunization Safety Review Committee “favors rejection of a causal relationship between thimerosal-containing vaccines and autism” (IOM, 2004).  Despite this finding, “all vaccines routinely recommended for children 6 years of age or younger and marketed in the U.S. contain no thimerosal or only trace amounts” (FDA, 2015).

“Infants and young children who follow immunization schedules that spread out shots – or leave out shots – are at risk of developing diseases during the time that shots are delayed” (CDC, 2016). Vaccines “keep communities healthy, and protect some of the most vulnerable in our society” (American Academy of Pediatrics, 2017).  The Delaware Academy of Medicine will continue to advocate for vaccines and vaccine use in the state of Delaware and the United States.

CCHS Global Health Residency Track

GLOBAL HEALTH SERIES

Please join us for this month’s global health talk!
The Global Health Residency Tracks of Christiana Care Health System, in partnership with the Delaware Academy of Medicine / Delaware Public Health Association, are pleased to invite you to this month’s global health talk.

Wednesday, May 15, 2019
5:30 – 6:30 pm
LIVE: Ammon Medical Education Center Room 14

Eligible but excluded: The protection of unaccompanied refugee minors in Greece

As an unprecedented number of refugees washed ashore Greek islands in 2015, numerous humanitarian organizations launched response efforts to provide displaced people with aid. Among these efforts were child protection projects for unaccompanied minors, who by some estimates made up 35% of the new arrivals in 2015. This talk presents the findings of a 2018-2019 study exploring how the development of immigration and refugee assistance policies systematically excluded certain categories of unaccompanied minors from accessing child protection programs that they were eligible for. Using the situation of unaccompanied refugee minors in Greece as a case study, this talk discusses how limited local knowledge in humanitarian response situations can lead to unintended consequences, and highlights management strategies that can respond to unexpected information.

Speakers:
Divya Mishra, PhD

REGISTER ONLINE

The CCHS Global Health Curriculum is an interdepartmental collaboration, supporting the Global Health Tracks in the Depts. of Medicine and Family Medicine, and the Med-Peds Residency, with the support of the Delaware Academy of Medicine, Delaware Public Health Association, and Delaware Academy of Family Physicians.

All are welcome to attend this talk.  Global Health Curriculum residents are required to attend.  There is no charge to attend this event, but registration is required. Food and Refreshments will be served.